The presence of SSTR2A staining in GLI1-altered mesenchymal tumors is a diagnostic pitfall that may lead to an erroneous diagnosis, especially in tumors arising in head and neck locations. This evidence concerns the gene GLI1 and mesenchymal cell neoplasm.